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Abstract
Background: An adverse hematological interaction between vitamins E and K has been reported,
primarily in patients on anticoagulants. However, little is known regarding circulating levels or
tissue concentrations of vitamin K in response to vitamin E supplementation. The purpose of this
study was to examine the effect of different levels of dietary α-tocopherol on phylloquinone and
menaquinone-4 concentrations, while maintaining a constant intake of phylloquinone, in rat tissues.
Methods: Male 4-wk old Fischer 344 rats (n = 33) were fed one of 3 diets for 12 wk: control (n
= 13) with 30 mg all-rac-α-tocopherol acetate/kg diet; vitamin E-supplemented (n = 10) with 100
mg all-rac-α-tocopherol acetate/kg diet; and vitamin E-restricted (n = 10) with <10 mg total
tocopherols/kg diet. All 3 diets contained 470 ± 80 μg phylloquinone/kg diet.
Results: Phylloquinone concentrations were lower (P ≤ 0.05) in the vitamin E-supplemented
compared to the vitamin E-restricted group (mean ± SD spleen: 531 ± 58 vs.735 ± 77; kidney: 20
± 17 vs. 94 ± 31, brain: 53 ± 19 vs.136 ± 97 pmol/g protein respectively); no statistically significant
differences between groups were found in plasma, liver or testis. Similar results were noted with
menaquinone-4 concentrations in response to vitamin E supplementation.
Conclusion: There appears to be a tissue-specific interaction between vitamins E and K when
vitamin E is supplemented in rat diets. Future research is required to elucidate the mechanism for
this nutrient-nutrient interaction.
Background
Although dietary vitamin E intakes are low relative to rec-
ommended intakes, vitamin E is among the most fre-
quently purchased single nutrient dietary supplements in
the US, particularly among older adults [1]. A systematic
review of the literature concluded that vitamin E dietary
supplements are safe for the general population [2]. How-
ever, vitamin E supplementation enhances the action of
coumarin-based oral anticoagulants, which are vitamin K
antagonists, and can result in bleeding episodes [3,4].
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Doses of vitamin E at the Tolerable Upper Level [5] can
also result in an increase in the under γ-carboxylation of
prothrombin, an indicator of poor vitamin K status, in
adults with normal coagulation status [6]. Doses of 600
IU of natural-source vitamin E administered on alterna-
tive days were associated with a modest increase in risk of
epistaxis in the Women's Health Study [7]. Collectively,
these outcomes suggest an interaction between vitamin E
and vitamin K in humans.
Vitamin K is a family of fat-soluble compounds with a
common chemical structure, 2, methyl-1,4-napthoqui-
none. Phylloquinone is present in food of plant origin,
such as green, leafy vegetables and certain plant oils, and
is the predominant form in the diet [8]. Bacterial and
other forms of vitamin K, referred to as the menaqui-
nones, differ in structure from phylloquinone in their 3-
substituted lipophilic side chain. Menaquinone-4 (MK-
4), which is alkylated from menadione [9], is present in
animal feeds or is the product of tissue-specific conversion
directly from dietary phylloquinone [10]. Vitamin K is a
cofactor specific to the formation of γ-carboxyglutamyl
(Gla) residues in certain proteins, including prothombin
necessary for normal hemostatic function [11]. The natu-
rally occurring forms of vitamin K are quinones (i.e. phyl-
loquinone and menaquinones) so vitamin K is reduced to
the vitamin K hydroquinone prior to catalyzing the γ-car-
boxylation reaction [11]. The active site for the carboxyla-
tion reaction is on the napthoquinone ring, which is
identical for all forms of vitamin K, including phylloqui-
none and MK-4.
One proposed mechanism for interactions between vita-
min E and vitamin K is the competitive inhibition of vita-
min K-dependent carboxylase by the vitamin E metabolite
tocopherol quinone [12]. This interaction between vita-
mins E and K may also be explained by a competitive
redox reaction between tocopherol quinone and the
reduced form of vitamin K, vitamin K hydroquinone,
which would result in a depletion of the cofactor for the
vitamin K-dependent carboxylase [13]. An alternative
hypothesis is that supraphysiologic doses of vitamin E
interferes with vitamin K activation of the pregnane X
receptor (PXR) [14].
High doses of vitamin E administered to vitamin K-defi-
cient animals result in abnormal coagulation as a conse-
quence of under γ-carboxylation of prothrombin, whereas
there is no effect of vitamin E supplementation in vitamin
K-adequate animals [15]. However, coagulation times are
not a sensitive indicator of vitamin K status and there are
few published studies on circulating levels or tissue con-
centrations of vitamin K in response to vitamin E supple-
mentation. Thus, we examined the effects of different
dietary levels of α-tocopherol on phylloquinone and
menaquinone-4 (MK-4) concentrations in rat plasma and
tissues.
Methods
Animals and diets
Male weanling (3 wk old) Fischer-344 rats (n = 78) were
obtained from Harlan (Dublin, VA) for a larger study that
examined the capacity of quercetin to serve as an in vivo
antioxidant [16]. Thirty-three (n = 33) of these rats were
also used for this study on the effect of vitamin E supple-
mentation on vitamin K status. Rats were individually
housed in wire bottom cages in the animal care facility of
the USDA Human Nutrition Research Center on Aging at
Tufts University, maintained at 25°C with a 12 h
light:dark cycle throughout the study. Rats were fed an
acclimation (control) diet consisting of 27 mg all-rac-α-
tocopherol acetate/kg diet for 1 wk, which is within the
National Research Council recommended intake [17]. A
modified vitamin E-restricted AIN-93 G purified basal mix
vitamin E stripped oil (<10 mg/kg total tocopherol) was
obtained from Dyets Inc. (Bethlehem, PA). Vitamin E
deficient and sufficient vitamin mixes were obtained from
Harlan Teklad (Madison, WI) and vitamin E was added in
varying concentrations to manipulate the vitamin E con-
tent of the diets. Samples of each diet were analyzed for
phylloquinone, and the diets were stored at -20°C under
nitrogen gas during the entire period of the study. Con-
centrations of all other nutrients were identical for all
three diets, and were with the National Research Council
recommended intakes [12].
Experimental protocol
After 1 wk acclimation, 4 wk old rats were weight-matched
and divided into dietary groups (n = 13/group) as follows:
(1) vitamin E-supplemented with 100 mg all-rac-α-toco-
pherol acetate/kg diet; (2) vitamin E-replete (control)
with 30 mg all-rac-α-tocopherol acetate/kg diet; and (3)
vitamin E-restricted with <10 mg total tocopherols/kg
diet. Tissues and plasma samples were only available for
10 vitamin E-supplemented and 10 vitamin E-restricted
rats for the purpose of these analyses.
Rats were pair-fed their respective diets for 12 wk. Each rat
was provided with weighed portions of that amount of the
diet consumed during the previous 24-h by the rat eating
the least amount in any of the three groups. At the end of
the feeding period, prior to sacrifice, the animals were
fasted for 2 h, anesthetized with Aerrane (Barter, Deer-
field, IL) and killed by CO2 asphyxiation. This protocol
was approved by the HNRCA Institutional Animal Care
and Use Committee.
Laboratory analyses
Tissues were harvested, quick frozen in liquid nitrogen,
and stored at -80°C until the time of analyses. TissuesNutrition & Metabolism 2006, 3:29 http://www.nutritionandmetabolism.com/content/3/1/29
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were homogenized using a Powergen homogenizer
(Fisher Scientific) with 5 mL phosphate-buffered saline.
The protein concentrations of all the homogenates were
determined using the DC Protein Assay (Bio-Rad, Her-
cules, CA)
The concentrations of phylloquinone and MK-4 in tissue
(liver, spleen, kidney, testis and whole brain), plasma,
and diets were determined by reverse phase high perform-
ance liquid chromatography (HPLC) as described by
Huber et al. [18]. Liver and testis homogenates, and
plasma were analyzed by HPLC for α-tocopherol, as
described by Martin et al. [19]. Homogenates of whole
brain and kidney were analyzed by HPLC for α-tocophe-
rol at a later date, in a different laboratory, for α-tocophe-
rol using the method described by Johnson and Russell
[20].
Statistical analysis
Data are reported as mean ± SEM. Multiple comparison
analyses were performed by one-way ANOVA followed by
the Bonferroni adjustment for multiple comparisons.
Data was analyzed using SPSS for Windows, version 11.0.
Significance was set at p ≤ 0.05.
Results
At the end of the 12-wk diet period, the mean body weight
(± SEM) of the rats in the control, vitamin E supple-
mented, and vitamin E-restricted groups was 276.4 ± 6.4,
277.0 ± 10.9, and 275.0 ± 6.5 g, respectively. Due to the
pair-feeding design, all rats were fed the same amount
daily, adjusted accordingly to the lowest diet intake. How-
ever, there were no differences in intake observed between
the diet groups. Daily inspection of the animals also did
not reveal any coagulation abnormalities during this
period. As expected, α-tocopherol concentrations for
plasma, liver, testis, brain and kidney increased with
increased  α-tocopherol intake (i.e. vitamin E-restricted
<control <vitamin E-supplemented) (Table 1). No data
were available for α-tocopherol concentrations in the
spleen.
Analysis of the 3 diets revealed a mean ± SD of 470 ± 80
μg phylloquinone/kg. These concentrations are below the
current dietary recommendation of 1000 μg phylloqui-
none/kg of diet [17]. This result was unexpected as stand-
ard rat chow and commercial vitamin mixes were used to
formulate the diets in compliance with National Research
Council values for rats [17]. Analysis of the vitamin E-
stripped soybean oil (<10 mg/kg total tocopherol) com-
pared to regular soybean oil indicated substantial losses of
phylloquinone associated with the process of stripping
vitamin E from the oil (10.1 vs. 179 μg/100 g oil for the
stripped vs. regular soybean oil, respectively).
Phylloquinone concentrations were lower in spleen
(Table 2), kidney and brain (Figure 1) among rats fed the
vitamin E-supplemented diet compared to those fed the
vitamin E-restricted diet for 12 wk. Although plasma phyl-
loquinone concentrations were statistically different
across the 3 diet groups, they were not different between
the vitamin E-supplemented and vitamin E-restricted
groups (Table 2). Similarly, hepatic phylloquinone con-
centrations did not differ significantly among the 3 diet
groups. Comparisons of phylloquinone concentrations
between the control group and either vitamin E-supple-
mented or vitamin E-restricted groups provided inconsist-
ent results across the tissues measured. MK-4
concentrations in plasma (Table 2), testis, kidney and
brain (Figure 2) were significantly lower in vitamin E-sup-
plemented compared to vitamin E-restricted, whereas
there were no differences in liver or spleen MK-4 across
the 3 groups (Table 2). Similar to phylloquinone, there
were inconsistent differences in MK-4 concentrations of
various tissues between the control group and the vitamin
E-supplemented or vitamin E-restricted groups.
Discussion
Vitamin K concentrations in extrahepatic tissue were gen-
erally lower in rats fed a vitamin E-supplemented diet
compared to those fed a vitamin E-deficient diet, while
maintaining a constant, albeit low intake of vitamin K.
The estimated requirement for vitamin E in the rat is 27
Table 1: Effect of 12 wk α-tocopherol supplementation (E+) or restriction (E-) on α-tocopherol concentrations in plasma and tissue of 
rats1,2,3
Tissue E+ (100 mg all-rac-α-tocopherol) Control (30 mg all-rac-α-
tocopherol)
E- (<10 mg total tocopherol)
n = 10 n = 13 n = 10
Plasma (μmol/L) 36 ± 6.0 20 ± 1.2 < 1.0
Liver (nmol/g protein) 2.08 ± 0.08 0.68 ± 0.04 0.007 ± 0.0005
Kidney (nmol/g protein) 1.97 ± 0.51 1.41 + 0.55 ND4
Brain (nmol/g protein) 1.90 ± 1.19 1.29 ± 0.29 0.59 ± 0.19
Testis (nmol/g protein) 1.19 ± 0.06 1.00 ± 0.06 0.026 ± 0.002
1All 3 diets contained 460 μg phylloquinone/kg of diet
2Plasma and tissue α-tocopherol in the E+ group are higher than those in the Control and E- groups (P ≤ 0.05)
3Values are mean ± SEM
4Not detectableNutrition & Metabolism 2006, 3:29 http://www.nutritionandmetabolism.com/content/3/1/29
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mg all-rac-α-tocopherol acetate/kg diet [17]. We noted a
decrease in vitamin K concentrations in response to a diet
formulated with 100 mg all-rac-α-tocopherol acetate/kg, a
dose higher than the estimated requirement for vitamin E,
but one commonly used in commercial rodent chows
[17].
We defined vitamin K status as phylloquinone and MK-4
concentrations in various rat tissues, although phylloqui-
none was the only form supplied in the diet per usual rec-
ommendations [17]. This study appears to be the first
report that both phylloquinone and MK-4 are decreased
in certain extrahepatic tissues in response to vitamin E
supplementation. Consistent with reports by others [21-
24], phylloquinone was the predominant form of vitamin
K in plasma and liver. However, there were no differences
in hepatic concentrations of phylloquinone across the
three diet groups in this study. Kindberg and Suttie
showed that plasma phylloquinone is elevated only after
the liver has adequate levels for complete γ-carboxylation
of hepatic proteins [21]. Thus, the relatively low concen-
tration of phylloquinone and MK-4 in extrahepatic tissues
across all three groups of rats because of low phylloqui-
none intakes may have allowed for a more marked effect
of vitamin E supplementation in these tissues compared
to the liver.
Although coagulation times were not monitored, we did
not observe any apparent bleeding abnormalities during
this 12 wk study. Abdo et al[25] reported hemorrhagic
abnormalities indicative of vitamin K deficiency, in rats
fed 2,000 mg RRR-α-tocopherol acetate/kg body weight
when using an AIN-76 diet low in vitamin K (provided as
Menaquinone-4 in kidney, testis, and brain tissues of rats fed  100 mg all-rac-α-tocopherol/kg diet (E+), 30 mg all-rac-α- tocopherol/kg diet (Control) or <10 mg total tocopherols/kg  diet (E-) for 12 wk Figure 2
Menaquinone-4 in kidney, testis, and brain tissues of rats fed 
100 mg all-rac-α-tocopherol/kg diet (E+), 30 mg all-rac-α-
tocopherol/kg diet (Control) or <10 mg total tocopherols/kg 
diet (E-) for 12 wk. Means (± SEM) with different superscript 
letters are significantly different, P < 0.05 (ANOVA with Bon-
ferroni Correction).
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Table 2: Effects of 12 wk α-tocopherol supplementation (E+) or restriction (E-) on phylloquinone and MK-4 concentrations in plasma 
and tissue of rats1,2,3
Phylloquinone MK-4
E+ (100 mg all-
rac-α-
tocopherol)
Control (30 mg 
all-rac-α-
tocopherol)
E- (<10 mg total 
tocopherol)
P E+ (100 mg 
all-rac-α-
tocopherol)
Control (30 
mg all-rac-α-
tocopherol)
E- (<10 mg 
total 
tocopherol)
P
n = 10 n = 13 n = 10 n = 10 n = 13 n = 10
Plasma (pmol/mL) 7.4 ± 0.7a 10.6 ± 0.8b 8.7 ± 0.9a 0.03 0.1 ± 0.3a 1.7 ± 0.7b 0.36 ± 0.1b 0.04
Liver (pmol/g protein) 670 ± 79a 698 ± 41a 643 ± 91a 0.86 ND4 0.9 ± 0.9 ND4 0.50
Spleen (pmol/g protein) 531 ± 58a 531 ± 48a 735 ± 77b 0.04 163 ± 30a 133 ± 19a 153 ± 29a 0.69
1All 3 diets contained 460 μg phylloquinone/kg of diet
2Values are mean ± SEM
3Means with different superscript letters are significantly different, P <0.05 (ANOVA with Bonferroni Correction)
4Not detectable
Phylloquinone in kidney, testis, and brain tissues of rats fed  100 mg all-rac-α-tocopherol/kg diet (E+), 30 mg all-rac-α- tocopherol/kg diet (Control) or <10 mg total tocopherols/kg  diet (E-) for 12 wk Figure 1
Phylloquinone in kidney, testis, and brain tissues of rats fed 
100 mg all-rac-α-tocopherol/kg diet (E+), 30 mg all-rac-α-
tocopherol/kg diet (Control) or <10 mg total tocopherols/kg 
diet (E-) for 12 wk. Means (± SEM) with different superscript 
letters are significantly different, P < 0.05 (ANOVA with Bon-
ferroni Correction).
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menadione sodium bisulfate). Using chicks, Frank et al.
[26] found an inhibitory effect of 4,000 mg all-rac-α-toco-
pherol acetate/kg diet on vitamin K status, as indicated by
elevated prothrombin time and increased bleeding ten-
dency. This effect was reversed by dietary phylloquinone
supplementation despite its lack of influence on α-toco-
pherol concentrations in plasma or liver. The latter obser-
vation is not unexpected as circulating levels of α-
tocopherol [5] are typically ~12,000 times greater than
those of phylloquinone [27] in humans, and were ~5,000
times greater than those of phylloquinone in the vitamin
E-supplemented group in this rat study. Therefore, it is
unlikely that increases in phylloquinone would have a
measurable impact on α-tocopherol concentrations. In
contrast, small increments in dietary α-tocopherol appear
able to affect the tissue content of phylloquinone and MK-
4 even though these doses are magnitudes greater than the
total vitamin K content. As no binding protein or receptor
is known to regulate vitamin K absorption, the mecha-
nism by which vitamin E interacts with vitamin K is
unclear.
MK-4 is primarily formed from dietary phylloquinone,
independent of intestinal bacteria, although the extent of
this conversion varies among different tissues [10]. We
found MK-4 concentrations to be lowest in the testis, kid-
ney, and brain of vitamin E-supplemented rats. For rea-
sons for which we currently do not have an explanation,
the ratio of phylloquinone to MK-4 in the brain of rats in
our study, regardless of their diet group, was higher com-
pared to other studies in which the MK-4 is the predomi-
nant form [24,28]. However, the amounts and ratios of
phylloquinone to MK-4 appear to vary with age and gen-
der [18], which may in part explain the differences. MK-4
was very low and/or non-detectable in plasma and liver in
all three diet groups, with no measurable differences in
response to vitamin E status. This observation is consist-
ent with the report by Davidson et al. [10] that hepatic cell
lines are less active in converting phylloquinone to MK-4
than renal cell lines. In contrast to phylloquinone, there
were no differences in MK-4 content of the spleen
between the three vitamin E diet groups. As the mecha-
nism by which phylloquinone is converted to MK-4 is
unknown, we cannot readily speculate how vitamin E
supplementation influences the concentrations of these
forms of vitamin K in extrahepatic tissue. While it is plau-
sible that less MK-4 is produced because vitamin E supple-
mentation reduces phylloquinone as a substrate in the
extrahepatic tissue, vitamin E may also decrease MK-4
concentrations independently of phylloquinone.
It is worth noting that Mitchell et al. [29] found intake of
a lutein mixture preserved with vitamin E resulted in
decreased absorption, uptake and/or transport of phyllo-
quinone and MK-4 in rats. Consistent with this result,
Takahashi [30] reported a hemorrhagic toxicity in rats fol-
lowing treatment with a pharmacological dose of fat solu-
ble nutrients, including vitamin E and β-carotene. In
contrast, we employed nutritional doses of α-tocopherol
while maintaining a constant intake of all other dietary
ingredients, including phylloquinone, though the range
of vitamin E intake was inadequate to examine a full dose-
response relationship. Additionally, the use of vitamin E-
stripped oil in the diet inadvertently reduced its phyllo-
quinone content and, thus, intake in the rats. Although
the phylloquinone intake appeared adequate to maintain
normal blood coagulation, it fell below recommended
intakes. It is not known if the same results would have
been found if the rats were fed a diet containing the rec-
ommended level of phylloquinone [17]. However, this
report appears to be the first to note that the common use
of vitamin E-stripped oil in formulating diets deficient or
low in vitamin E for animal model experiments also
results in low vitamin K diets and intakes.
Conclusion
In summary, vitamin E supplementation in rats decreases
vitamin K status in several extrahepatic tissues. These
results suggest that new studies are warranted where func-
tional measures of vitamin K status, e.g., the degree of γ-
carboxylation of vitamin K-dependent proteins, could
provide some insight into the potential mechanism and
physiological significance of this vitamin E-vitamin K
interaction.
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